These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10091160)

  • 1. Glucose disturbances and regulation with glibenclamide in thalassemia.
    Ladis V; Theodorides C; Palamidou F; Frissiras S; Berdousi H; Kattamis C
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():871-8. PubMed ID: 10091160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus.
    Gudat U; Bungert S; Kemmer F; Heinemann L
    Diabet Med; 1998 Mar; 15(3):194-8. PubMed ID: 9545119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization.
    Jacobson GF; Ramos GA; Ching JY; Kirby RS; Ferrara A; Field DR
    Am J Obstet Gynecol; 2005 Jul; 193(1):118-24. PubMed ID: 16021069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy.
    Yogev Y; Ben-Haroush A; Chen R; Rosenn B; Hod M; Langer O
    Obstet Gynecol; 2004 Jul; 104(1):88-93. PubMed ID: 15229005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia.
    Ramos GA; Jacobson GF; Kirby RS; Ching JY; Field DR
    J Perinatol; 2007 May; 27(5):262-7. PubMed ID: 17363911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y; DeFronzo RA
    Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal glucose tolerance in beta-thalassemia: assessment of risk factors.
    Hafez M; Youssry I; El-Hamed FA; Ibrahim A
    Hemoglobin; 2009; 33(2):101-8. PubMed ID: 19373585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of glucose intolerance and diabetes in transfused patients with thalassemia.
    Kattamis C; Ladis V; Tsoussis D; Kaloumenou I; Theodoridis C
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():267-71. PubMed ID: 16462709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.
    Moncada Lorenzo E; Garcia RV; Barberia Layana JJ; Morant Ciscard JA; Calleja Canelas A
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):50-7. PubMed ID: 401712
    [No Abstract]   [Full Text] [Related]  

  • 10. Correction of hyperinsulinemia by glyburide treatment in nondiabetic patients with thalassemia major.
    Jones TW; Boulware SD; Caprio S; Merkel P; Amiel SA; Pearson HA; Sherwin RS; Tamborlane WV
    Pediatr Res; 1993 May; 33(5):497-500. PubMed ID: 8511023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes.
    Tan MH; Johns D; Strand J; Halse J; Madsbad S; Eriksson JW; Clausen J; Konkoy CS; Herz M;
    Diabet Med; 2004 Aug; 21(8):859-66. PubMed ID: 15270789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
    Chazova I; Almazov VA; Shlyakhto E
    Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of glucose disturbances with glibenclamide in patients with thalassemia.
    Ladis V; Theodorides C; Palamidou F; Frissiras S; Berdousi H; Kattamis C
    Ann N Y Acad Sci; 1998 Jun; 850():471-4. PubMed ID: 9668588
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of diabetes mellitus and impaired glucose tolerance in beta-thalassemia patients with and without hepatitis C virus infection.
    Mowla A; Karimi M; Afrasiabi A; De Sanctis V
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():282-4. PubMed ID: 16462712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of octreotide on glucose and insulin levels in a patient with type 2 diabetes on glibenclamide.
    Lee PE; Meneilly GS
    Diabetes Metab; 1999 Sep; 25(4):347-9. PubMed ID: 10566126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral management of uncomplicated maturity onset diabetes.
    Mashaly M; el-Ebrashy N; Higazi AM; Einen MA; Aziz MT
    J Egypt Med Assoc; 1974; 57(7-8):288-97. PubMed ID: 4217809
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.
    Eriksson JG; Lehtovirta M; Ehrnström B; Salmela S; Groop L
    J Intern Med; 2006 Jun; 259(6):553-60. PubMed ID: 16704555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
    Hung YJ; Lin SH; Pei D; Kuo SW; Hsieh CH; He CT; Hsing Lee C; Fan SC; Sheu WH
    Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of glibenclamide on the glucose and insulin profile in maturity onset diabetics following both acute and long term treatment.
    Owens DR; Biggs PI; Shetty KJ; Wragg KG
    Diabete Metab; 1980 Sep; 6(3):219-24. PubMed ID: 6777211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.